Cargando…

Syndecan-2 Methylation as a New Biomarker for Early Detection of Colorectal Neoplasm

Detalles Bibliográficos
Autores principales:	Kim, Ji Hyun, Park, Sung Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143450/ https://www.ncbi.nlm.nih.gov/pubmed/30205668 http://dx.doi.org/10.5009/gnl18286

Ejemplares similares

Analysis of Syndecan-2 Methylation in Bowel Lavage Fluid for the Detection of Colorectal Neoplasm
por: Park, Young Sook, et al.
Publicado: (2018)

Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA
por: Han, Yoon Dae, et al.
Publicado: (2019)

Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer
por: Song, Ji Hyeong, et al.
Publicado: (2023)

Syndecan-2: Old Player in a New Field
por: Obraztsova, Kseniya, et al.
Publicado: (2019)

The stool syndecan2 methylation test is more robust than blood tests for methylated septin9, CEA, CA19-9 and CA724: a diagnostic test for the early detection of colorectal neoplasms
por: Zhan, Yixiang, et al.
Publicado: (2023)

A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA
por: Ma, Liang, et al.
Publicado: (2022)

Female hormones and the risk of colorectal neoplasm
por: Jung, Yunho
Publicado: (2019)

Substituted Syndecan-2-Derived Mimetic Peptides Show Improved Antitumor Activity over the Parent Syndecan-2-Derived Peptide
por: Jang, Bohee, et al.
Publicado: (2022)

Metabolomics Biomarkers for Detection of Colorectal Neoplasms: A Systematic Review
por: Erben, Vanessa, et al.
Publicado: (2018)

The Application Value of Syndecan-2 Gene Methylation for Colorectal Cancer Diagnosis: A Clinical Study and Meta-Analyses
por: Yue, Congbo, et al.
Publicado: (2022)

Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer
por: Su, Wei-Chih, et al.
Publicado: (2021)

Usefulness of artificial intelligence in gastric neoplasms
por: Kim, Ji Hyun, et al.
Publicado: (2021)

Blood-based DNA Methylation Biomarkers for Early Detection of Colorectal Cancer
por: Dong, Lixn, et al.
Publicado: (2018)

Molecular Diagnostics, Pathology and Biomarkers of Gastrointestinal Neoplasms
por: Gurzu, Simona
Publicado: (2023)

The Synchronous Prevalence of Colorectal Neoplasms in Patients with Stomach Cancer
por: Lee, Ryung Ah
Publicado: (2011)

Finding a New Prognostic Biomarker for Metastatic Colorectal Cancer
por: Kim, Hungdai
Publicado: (2012)

Syndecan-3 as a Novel Biomarker in Alzheimer’s Disease
por: Hudák, Anett, et al.
Publicado: (2022)

Syndecan-1 as a severity biomarker for patients with trauma
por: Suzuki, Keiko, et al.
Publicado: (2022)

Combining methylated SDC2 test in stool DNA, fecal immunochemical test, and tumor markers improves early detection of colorectal neoplasms
por: Zeng, Tao, et al.
Publicado: (2023)

SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer
por: Zhang, Weisong, et al.
Publicado: (2021)

Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets
por: Oto, Julia, et al.
Publicado: (2023)

Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer
por: Oh, Tae Jeong, et al.
Publicado: (2017)

The Cardiac Syndecan-2 Interactome
por: Mathiesen, Sabrina Bech, et al.
Publicado: (2020)

Syndecan‐4, a model proteoglycan to study endothelial glycocalyx mechanosensing and signal transduction
por: van den Berg, Bernard M.
Publicado: (2019)

Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms
por: Koenig, Alexander, et al.
Publicado: (2017)

The role of microvesicles as biomarkers in the screening of colorectal neoplasm
por: Eddama, Mohammad M. R., et al.
Publicado: (2022)

Colorectal Cancer: Advances in Prevention and Early Detection
por: Miles, Anne, et al.
Publicado: (2015)

The association between cecal insertion time and colorectal neoplasm detection
por: Yang, Moon Hee, et al.
Publicado: (2013)

Serum-Based DNA Methylation Biomarkers in Colorectal Cancer: Potential for Screening and Early Detection
por: Summers, Thomas, et al.
Publicado: (2013)

Promoter Methylation of QKI as a Potential Specific Biomarker for Early Detection of Colorectal Cancer
por: Zhang, Lei, et al.
Publicado: (2022)

SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer [Corrigendum]
Publicado: (2022)

Application of Artificial Intelligence in the Detection and Characterization of Colorectal Neoplasm
por: Kim, Kyeong Ok, et al.
Publicado: (2021)

Biomarkers for Early Detection of Cancer: Molecular Aspects
por: Tappia, Paramjit S., et al.
Publicado: (2023)

Syndecan-1 Expression Is Associated with Tumor Size and EGFR Expression in Colorectal Carcinoma: A Clinicopathological Study of 230 Cases
por: Kim, Su Young, et al.
Publicado: (2015)

Syndecan-1 Enhances Proliferation, Migration and Metastasis of HT-1080 Cells in Cooperation with Syndecan-2
por: Péterfia, Bálint, et al.
Publicado: (2012)

Syndecan-3 and syndecan-4 are enriched in Schwann cell perinodal processes
por: Goutebroze, Laurence, et al.
Publicado: (2003)

Immunohistochemical Expression of Heparanase Isoforms and Syndecan-1 Proteins in Colorectal Adenomas
por: Waisberg, J., et al.
Publicado: (2016)

Periodontitis is associated with an increased risk for proximal colorectal neoplasms
por: Kim, Gun Woo, et al.
Publicado: (2019)

Early Colorectal Epithelial Neoplasm in Korea: A Multicenter Survey of Pathologic Diagnosis
por: Kang, Yun Kyung, et al.
Publicado: (2013)

Shed syndecan-2 inhibits angiogenesis
por: De Rossi, Giulia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gfmgnlbhthho06270hm5a8trua